{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:11:29Z","timestamp":1785496289987,"version":"3.56.0"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>Leishmaniasis is a spectrum of neglected tropical diseases and its cutaneous form (CL) is characterized by papillary or ulcerated skin lesions that negatively impact patients' quality of life. Current CL treatments suffer limitations, such as severe side effects and high cost, making the search for new therapeutic alternatives an imperative. In this context, heat shock protein 90 (Hsp90) could present a novel therapeutic target, as evidence suggests that Hsp90 inhibitors, such as 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG), may represent promising chemotherapeutic agents against CL. As innovative input for formulation development of 17-DMAG, nano-based drug delivery systems could provide controlled release, targeting properties, and reduced drug toxicity. In this work, a double emulsion method was used to develop poly (lactic-co-glycolic acid) (PLGA) nanoparticles containing 17-DMAG. The nanoparticle was developed using two distinct protocols: Protocol 1 (P1) and Protocol 2 (P2), which differed concerning the organic solvent (acetone or dichloromethane, respectively) and procedure used to form double-emulsions (Ultra-Turrax\u00ae homogenization or sonication, respectively). The nanoparticles produced by P2 were comparatively smaller (305.5 vs. 489.0 nm) and more homogeneous polydispersion index (PdI) (0.129 vs. 0.33) than the ones made by P1. Afterward, the P2 was optimized and the best composition consisted of 2 mg of 17-DMAG, 100 mg of PLGA, 5% of polyethylene glycol (PEG 8000), 1.5 mL of the internal aqueous phase, 1% of polyvinyl alcohol (PVA), and 4 mL of the organic phase. Optimized P2 nanoparticles had a particle size of 297.2 nm (288.6\u2013304.1) and encapsulation efficacy of 19.35% (15.42\u201342.18) by the supernatant method and 31.60% (19.9\u201348.79) by the filter\/column method. Release kinetics performed at 37\u00b0C indicated that ~16% of the encapsulated 17-DMAG was released about to 72 h. In a separate set of experiments, a cell uptake assay employing confocal fluorescence microscopy revealed the internalization by macrophages of P2-optimized rhodamine B labeled nanoparticles at 30 min, 1, 2, 4, 6, 24, 48, and 72 h. Collectively, our results indicate the superior performance of P2 concerning the parameters used to assess nanoparticle development. Therefore, these findings warrant further research to evaluate optimized 17-DMAG-loaded nanoparticles (NP2-17-DMAG) for toxicity and antileishmanial effects <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>.<\/jats:p>","DOI":"10.3389\/fchem.2021.644827","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T09:18:03Z","timestamp":1620983883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor"],"prefix":"10.3389","volume":"9","author":[{"given":"Kercia P.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz F. C.","family":"Patricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius C.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina F.","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G. S. F.","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenita C.","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A. S.","family":"Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo H. C.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio R.","family":"Formiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helv\u00e9cio V. A.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia S. T.","family":"Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nnm-2018-0038","article-title":"Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis","volume":"14","author":"Afzal","year":"2019","journal-title":"Nanomedicine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1021\/nl301452x","article-title":"Separation of nanoparticles in aqueous multiphase systems through centrifugation","volume":"12","author":"Akbulut","year":"2012","journal-title":"Nano Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2741\/4629","article-title":"Leishmaniasis treatment: update of possibilities for drug repurposing","volume":"23","author":"Andrade-Neto","year":"2018","journal-title":"Front. Biosci. Landmark"},{"key":"B5","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1163\/156856206775997322","article-title":"Synthesis and characterization of PLGA nanoparticles","volume":"17","author":"Astete","year":"2006","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"B6","volume-title":"Manual de recomenda\u00e7\u00f5es para diagn\u00f3stico, tratamento e acompanhamento de pacientes com a coinfec\u00e7\u00e3o Leishmania-HIV, 1st Edn","year":"2015"},{"key":"B7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.bbrc.2007.08.054","article-title":"Hsp90-From signal transduction to cell transformation","volume":"363","author":"Brown","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0001-706X(94)90103-1","article-title":"Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis","volume":"56","author":"Carvalho","year":"1994","journal-title":"Acta Trop."},{"key":"B10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1359-6446(04)03245-3","article-title":"Hsp90: the vulnerable chaperone","volume":"9","author":"Chiosis","year":"2004","journal-title":"Drug Discov. Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","article-title":"A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles","volume":"133","author":"Cohen-Sela","year":"2009","journal-title":"J. Control. Release"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105595","DOI":"10.1016\/j.actatropica.2020.105595","article-title":"Solid lipid nanoparticles as a novel formulation approach for tanespimycin (17-AAG) against leishmania infections: Preparation, characterization and macrophage uptake","volume":"211","author":"Couto","year":"2020","journal-title":"Acta Trop."},{"key":"B13a","first-page":"399","article-title":"Current scenario of drug development for leishmaniasis","volume":"123","author":"Croft","year":"2006","journal-title":"Indian J. Med. Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1155\/2015\/815023","article-title":"Advances in development of new treatment for leishmaniasis","volume":"2015","author":"De Menezes","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00280-001-0380-8","article-title":"Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD 2f 1 mice and fischer 344 rats","volume":"49","author":"Egorin","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbagrm.2013.12.006","article-title":"Regulatory role of the 90-kDa-heat-shock protein (Hsp90) and associated factors on gene expression","volume":"1839","author":"Erlejman","year":"2014","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"B17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4161\/biom.23246","article-title":"Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying","volume":"2","author":"Fonte","year":"2012","journal-title":"Biomatter"},{"key":"B18","first-page":"41","author":"Formiga","year":"2009","journal-title":"Nanosistemas a base de poli\u00e9steres. Nanotecnolog\u00eda Farm. Real. y posibilidades Farmacoter"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"12941","DOI":"10.1021\/la502144z","article-title":"Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs","volume":"30","author":"Garbuzenko","year":"2014","journal-title":"Langmuir"},{"key":"B21","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/EC.1.6.936-943.2002","article-title":"Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation","volume":"1","author":"Graefe","year":"2002","journal-title":"Eukaryot. Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijpddr.2018.02.005","article-title":"17-DMAG inhibits the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice","volume":"8","author":"Guswanto","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/C9RA10857B","article-title":"PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters","volume":"10","author":"Hern\u00e1ndez-Giottonini","year":"2020","journal-title":"RSC Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Hirenkumar","year":"2012","journal-title":"Polymers (Basel)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/cmi.12057","article-title":"The Hsp90-Sti1 interaction is critical for Leishmania donovani proliferation in both life cycle stages","volume":"15","author":"Hombach","year":"2013","journal-title":"Cell. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1242\/jcs.157297","article-title":"A small heat shock protein is essential for thermotolerance and intracellular survival of Leishmania donovani","volume":"127","author":"Hombach","year":"2014","journal-title":"J. Cell Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00396-014-3464-9","article-title":"Preparation of biodegradable PCL particles via double emulsion evaporation method using ultrasound technique","volume":"293","author":"Iqbal","year":"2015","journal-title":"Colloid Polym. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4155\/tde.14.91","article-title":"PLGA: a unique polymer for drug delivery","volume":"6","author":"Kapoor","year":"2015","journal-title":"Ther. Deliv."},{"key":"B29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2147\/ijn.s24547","article-title":"Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid","volume":"6","author":"Keum","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00436-009-1582-y","article-title":"Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage","volume":"105","author":"Li","year":"2009","journal-title":"Parasitol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1021\/acs.chemrev.5b00534","article-title":"Introduction: nanoparticles in medicine","volume":"115","author":"Lin","year":"2015","journal-title":"Chem. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jps.21406","article-title":"Zidovudine-loaded PLA and PLA\u2013PEG blend nanoparticles: influence of polymer type on phagocytic uptake by polymorphonuclear cells","volume":"98","author":"Mainardes","year":"2009","journal-title":"Pharm. Nanotechnol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3315\/jdcr.2013.1135","article-title":"Old world cutaneous leishmaniasis: diagnosis and treatment","volume":"7","author":"Masmoudi","year":"2013","journal-title":"J. Dermatol. Case Rep."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3791\/51015","article-title":"PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS","author":"McCall","year":"2013","journal-title":"J. Vis. Exp."},{"key":"B36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/microorganisms7120695","article-title":"Protective or detrimental? understanding the role of host immunity in leishmaniasis","volume":"7","author":"Meira","year":"2019","journal-title":"Microorganisms"},{"key":"B37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.colsurfb.2017.07.038","article-title":"Recent applications of PLGA based nanostructures in drug delivery","volume":"159","author":"Mir","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.intimp.2011.05.014","article-title":"The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response","volume":"11","author":"Nicolete","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apjtm.2016.06.021","article-title":"Worldwide risk factors in leishmaniasis","volume":"9","author":"Oryan","year":"2016","journal-title":"Asian Pac. J. Trop. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"37964","DOI":"10.1074\/jbc.M110.155317","article-title":"Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug","volume":"285","author":"Pallavi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"14756","DOI":"10.1038\/s41598-019-51239-0","article-title":"A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90","volume":"9","author":"Palma","year":"2019","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2018.00303","article-title":"Encapsulation of the HSP-90 chaperone inhibitor 17-AAG in stable liposome allow increasing the therapeutic index as assessed, in vitro, on Leishmania (L) amazonensis amastigotes-hosted in mouse CBA macrophages","volume":"8","author":"Petersen","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e49496","DOI":"10.1371\/journal.pone.0049496","article-title":"17-AAG Kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages","volume":"7","author":"Petersen","year":"2012","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/153537020322800201","article-title":"Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery","volume":"228","author":"Pratt","year":"2003","journal-title":"Exp. Biol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"118997","DOI":"10.1016\/j.ijpharm.2019.118997","article-title":"Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis","volume":"576","author":"Quadros","year":"2020","journal-title":"Int. J. Pharm."},{"key":"B46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded Plga and Plga-Peg nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B47","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1590\/S0100-40422003000400018","article-title":"Antimoniais empregados no tratamento da leishmaniose: Estado da arte","volume":"26","author":"Rath","year":"2003","journal-title":"Quim. Nova"},{"key":"B48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2016.01.021","article-title":"Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release","volume":"500","author":"Rietscher","year":"2016","journal-title":"Int. J. Pharm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/02652040500286185","article-title":"Effect of various formulation parameters on the properties of polymeric nanoparticles prepared by multiple emulsion method","volume":"23","author":"Rizkalla","year":"2006","journal-title":"J. Microencapsul."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27494","article-title":"Purification of Nanoparticles by Size and Shape","volume":"6","author":"Robertson","year":"2016","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bbamcr.2011.12.003","article-title":"Heat shock protein 90 from neglected protozoan parasites","volume":"1823","author":"Roy","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijpharm.2015.10.037","article-title":"Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses","volume":"496","author":"Salvador","year":"2015","journal-title":"Int. J. Pharm."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e3275","DOI":"10.1371\/journal.pntd.0003275","article-title":"Chemotherapeutic potential of 17-AAG against cutaneous Leishmaniasis caused by Leishmania (Viannia) braziliensis","volume":"8","author":"Santos","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","article-title":"Leishmaniasis treatment\u2014a challenge that remains: a review","volume":"103","author":"Santos","year":"2008","journal-title":"Parasitol. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1179\/joc.2004.16.Supplement-1.68","article-title":"Geldanamycin analogs","volume":"16","author":"Sausville","year":"2004","journal-title":"J. Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/1874104501105010031","article-title":"Structures, targets, and recent approaches in anti-leishmanial drug discovery and development","volume":"5","author":"Seifert","year":"2011","journal-title":"Open Med. Chem. J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.partic.2019.06.004","article-title":"A comparison of centrifugation and tangential flow filtration for nanoparticle purification: a case study on acetalated dextran nanoparticles","volume":"50","author":"Shah","year":"2020","journal-title":"Particuology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-3155-12-5","article-title":"Engineered nanoparticles interacting with cells: size matters","volume":"12","author":"Shang","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/15748928113089990031","article-title":"HSP90 inhibitors: current development and potential in cancer therapy","volume":"9","author":"Sidera","year":"2013","journal-title":"Recent Pat. Anticancer. Drug Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drudis.2007.10.007","article-title":"Development and application of Hsp90 inhibitors","volume":"13","author":"Solit","year":"2008","journal-title":"Drug Discov. Today"},{"key":"B63","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors"},{"key":"B64","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/nano9091240","article-title":"Influence of solvent evaporation technique parameters on diameter of submicron lamivudine-poly-\u03b5-caprolactone conjugate particles","volume":"9","author":"Urbaniak","year":"2019","journal-title":"Nanomaterials"},{"key":"B66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/2212711906666190724145101","article-title":"Use of nanoparticles in medicine","volume":"6","author":"Utreja","year":"2020","journal-title":"Curr. Biochem. Eng."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.2217\/nnm-2020-0317","article-title":"Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic- co -glycolic acid) nanoparticles in macrophages","volume":"15","author":"Van Hees","year":"2020","journal-title":"Nanomedicine"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/ijms17081270","article-title":"Using proteomics to understand how Leishmania parasites survive inside the host and establish infection","volume":"17","author":"Veras","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bbamcr.2011.12.006","article-title":"HSP90 as a platform for the assembly of more effective cancer chemotherapy","volume":"1823","author":"Whitesell","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B70","unstructured":"Leishmaniasis"},{"key":"B71","first-page":"265","volume-title":"Weekly Epidemiological Record","year":""},{"key":"B72","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1091\/mbc.12.11.3307","article-title":"Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani","volume":"12","author":"Wiesgigl","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","article-title":"Safety of nanoparticles in medicine","volume":"16","author":"Wolfram","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.2174\/138955706778560166","article-title":"Effectiveness of Hsp90 inhibitors as anti-cancer drugs","volume":"6","author":"Xiao","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicological considerations of clinically applicable nanoparticles","volume":"6","author":"Yildirimer","year":"2011","journal-title":"Nano Today"},{"key":"B76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0168-3659(97)00106-5","article-title":"Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method","volume":"50","author":"Zambaux","year":"1998","journal-title":"J. Control. Release"},{"key":"B77","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/1573413712666161018144519","article-title":"Polymersomes in nanomedicine\u2013a review","volume":"13","author":"Zhang","year":"2017","journal-title":"Curr. Nanosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1139\/o05-158","article-title":"Hsp90: a chaperone for protein folding and gene regulation","volume":"83","author":"Zhao","year":"2005","journal-title":"Biochem. Cell Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev.mi.48.100194.002313","article-title":"The role of pH and temperature in the development of leishmania parasites","volume":"48","author":"Zilberstein","year":"1994","journal-title":"Annu. Rev. Microbiol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2021.644827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T09:18:11Z","timestamp":1620983891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2021.644827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":81,"alternative-id":["10.3389\/fchem.2021.644827"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2021.644827","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"644827"}}